@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T48G1VCP-9 skos:prefLabel "Quinuclidines"@en, "Quinuclidines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZJ6JRJBR-8 . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZJ6JRJBR-8 dc:modified "2018-05-21"^^xsd:date ; mesh:allowableQualifier jvr:-NFTHND7Q-8, jvr:-Q3979798-W, jvr:-HQRFT0C6-B, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-G30ZJ446-J, jvr:-R3QWLHRG-V, jvr:-G4R176S9-J, jvr:-TJHVZCRZ-0, jvr:-L6C0XPHT-4, jvr:-CB30NGKB-3, jvr:-W6SQV79N-S, jvr:-H7K65Q8S-Z, jvr:-NHL3D2X0-S, jvr:-S0CS1X5R-5, jvr:-D0F21513-5, jvr:-SBNWSM1T-R, jvr:-T9HQD7ST-J, jvr:-THHNVC7V-3, jvr:-WK5F724J-1, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-XV06LPML-W, jvr:-BT300B3G-Q, jvr:-M63HSDM7-1 ; skos:broader jvr:-T48G1VCP-9, jvr:-ZWDWKD40-Q ; skos:hiddenLabel "RS-25259"@fr, "RS-25233-197"@en, "RS-25233-197"@fr, "RS 25233-198"@en, "RS-25259"@en, "Palonosetron, (S-(R*,S*))-isomer"@en, "Palonosetron, (3R)-"@en, "RS 25259-198"@en, "Palonosetron, (R-(R*,R*))-isomer"@en, "RS-25259-197"@en, "RS-25259-197"@fr, "Chlorhydrate de palonosétron"@fr, "Palonosetron Hydrochloride"@en, "RS-25233-198"@fr, "RS-25233-198"@en, "2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one"@en, "RS-25259-198"@fr, "RS-25259-198"@en, "RS 25233-197"@en, "Palonosetron, (R-(R*,S*))-isomer"@en, "RS 25259"@en, "Aloxi"@en, "RS 25259-197"@en ; a mesh:Descriptor, skos:Concept ; dc:created "2018-07-09"^^xsd:date ; skos:altLabel "5D06587D6R"@en, "5D06587D6R"@fr, "2UCB21ER4V"@fr, "2UCB21ER4V"@en, "1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-"@fr, "1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-"@en, "2-QHBIQO"@en, "23310D4I19"@fr, "23310D4I19"@en, "135729-61-2 (Palonosetron)"@fr, "135729-61-2 (Palonosetron)"@en ; skos:definition "Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting."@en ; mesh:pharmacologicalAction jvr:-X1H75KMP-P, jvr:-J79NNVZV-S ; skos:prefLabel "Palonosétron"@fr, "Palonosetron"@en ; dc:established "2019-01-01"^^xsd:date ; owl:sameAs ; skos:inScheme jvr: . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-ZWDWKD40-Q skos:prefLabel "Isoquinoléines"@fr, "Isoquinolines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZJ6JRJBR-8 . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-J79NNVZV-S skos:prefLabel "Antagonistes des récepteurs 5-HT3 de la sérotonine"@fr, "Serotonin 5-HT3 Receptor Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-X1H75KMP-P skos:prefLabel "Antiemetics"@en, "Antiémétiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .